These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16446973)

  • 21. Etiopathogenesis of cholesteatoma.
    Olszewska E; Wagner M; Bernal-Sprekelsen M; Ebmeyer J; Dazert S; Hildmann H; Sudhoff H
    Eur Arch Otorhinolaryngol; 2004 Jan; 261(1):6-24. PubMed ID: 12835944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Basic fibroblast growth factor (b-FGF) in the perimatrix of cholesteatoma].
    Milewski C; Fedorowski A; Stan AC; Walter GF
    HNO; 1998 Sep; 46(9):804-8. PubMed ID: 9816534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?
    Ayache S; Tramier B; Strunski V
    Otol Neurotol; 2008 Dec; 29(8):1085-90. PubMed ID: 18836388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hystology findings' correlation between the ossicular chain in the transoperative and cholesteatomas.
    Dornelles C; Schmidt Rosito LP; Meurer L; da Costa SS; Argenta A; Alves SL
    Braz J Otorhinolaryngol; 2007; 73(6):738-743. PubMed ID: 18278219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphological considerations about middle ear cholesteatoma.
    Măru N; Pop F
    Rom J Morphol Embryol; 2006; 47(1):73-7. PubMed ID: 16838062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Chlamydia pneumoniae in cholesteatoma tissue: any pathogenetic role?
    Ronchetti F; Ronchetti R; Guglielmi F; Chiappini I; Contini C; Filipo R; Santino I; Cerruto R; Bernardeschi D; Barbara M
    Otol Neurotol; 2003 May; 24(3):353-7. PubMed ID: 12806283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eustachian tube dysfunction in the pathogenesis of cholesteatoma: clinical considerations.
    Chao WY; Tseng HZ; Chang SJ
    J Otolaryngol; 1996 Oct; 25(5):334-8. PubMed ID: 8902694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Updates and knowledge gaps in cholesteatoma research.
    Kuo CL; Shiao AS; Yung M; Sakagami M; Sudhoff H; Wang CH; Hsu CH; Lien CF
    Biomed Res Int; 2015; 2015():854024. PubMed ID: 25866816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Congenital cholesteatomas in Japanese--forty from our experience and fifty-five from a survey of the Japanese literature].
    Suetake M; Kobayashi T; Sasaki N; Takasaka T; Yuasa R
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Sep; 99(9):1200-7. PubMed ID: 8914417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of the expression of E-cadherin, β-catenin, and β1 integrin in congenital and acquired cholesteatoma.
    Lee DW; Chung JH; Lee SH; Park CW; Kang SH; Oh YH; Pyo JY
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):845-51. PubMed ID: 25864182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perimatrix of middle ear cholesteatoma: A granulation tissue with a specific transcriptomic signature.
    Jovanovic I; Zivkovic M; Djuric T; Stojkovic L; Jesic S; Stankovic A
    Laryngoscope; 2020 Apr; 130(4):E220-E227. PubMed ID: 31132150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of pediatric cholesteatoma.
    Isaacson G
    Pediatrics; 2007 Sep; 120(3):603-8. PubMed ID: 17766534
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of p63 and survivin in cholesteatomas.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
    Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology of middle ear and mastoid cholesteatomas: study of 1146 cases.
    Aquino JE; Cruz Filho NA; de Aquino JN
    Braz J Otorhinolaryngol; 2011 Jun; 77(3):341-7. PubMed ID: 21739009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classification of Cholesteatoma According to Growth Patterns.
    Rosito LS; Netto LF; Teixeira AR; da Costa SS
    JAMA Otolaryngol Head Neck Surg; 2016 Feb; 142(2):168-72. PubMed ID: 26747599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Expression of transforming growth factor-beta1 and c-fos and p27 in human middle ear cholesteatoma].
    Jiang CW; Zhan HM; Wang WH; Zhang L; Jin SZ; Yang YB; Zhang ZJ
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):211-5. PubMed ID: 15283280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental cholesteatoma: a comparison between spontaneous and induced models.
    Huve FDC; Bauer JA; Selaimen FA; Silva MNLD; Costa SSD
    Braz J Otorhinolaryngol; 2023; 89(1):73-78. PubMed ID: 34810121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of pediatric cholesteatomas.
    Shirazi MA; Muzaffar K; Leonetti JP; Marzo S
    Laryngoscope; 2006 Sep; 116(9):1603-7. PubMed ID: 16954988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolated Incudostapedial Cholesteatomas: Unique Radiologic and Surgical Features.
    MacDonald B; Bommakanti K; Mallo M; Carvalho D
    Ear Nose Throat J; 2021 Jun; 100(3_suppl):243S-248S. PubMed ID: 33237827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alterations of the basal membrane in middle ear cholesteatoma].
    Bernal Sprekelsen M; Ebmeyer J; Anonopoulos A; Borkowski G; Sudhoff H
    Acta Otorrinolaringol Esp; 2001 May; 52(4):330-5. PubMed ID: 11526629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.